Magnetic resonance imaging in aggressive fibromatosis.
The magnetic resonance imaging (MRI) features of aggressive fibromatosis in 11 patients (five with recurrent tumour) and its contribution to patient management are described. Tumour signal intensity ranged from being low to isointense with respect to muscle on T1-weighted images while being predominantly of heterogenous increased signal intensity on T2-weighted images. A post-contrast (Gd-DTPA) study demonstrating diffuse tumour enhancement was of value in assessing tumour extent in two patients. CT in six patients and angiography in two patients provided no additional information while tumour relationship to neurovascular structures and extent was better appreciated on MRI. MRI was accurate in predicting resectability in all six patients who had surgery.
O'Keefe
F
F
Department of Diagnostic Radiology, University of Texas, M. D. Anderson Cancer Center, Houston 77030.
Kim
E E
EE
Wallace
S
S
D000293:Adolescent; D000328:Adult; D001808:Blood Vessels / Q000473:pathology; D001917:Brachial Plexus / Q000473:pathology; D005260:Female; D005350:Fibroma / Q000175:diagnosis* / Q000473:pathology; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009942:Organometallic Compounds; D010386:Pelvic Neoplasms / Q000175:diagnosis / Q000473:pathology; D004369:Pentetic Acid
D009942:Organometallic Compounds; D004369:Pentetic Acid; D019786:Gadolinium DTPA